NasdaqGS - Nasdaq Real Time Price
USD
Allogene Therapeutics, Inc. (ALLO)
1.1800
-0.0700
(-5.60%)
At close: October 30 at 4:00:01 PM EDT
1.1999
+0.0199
(+1.69%)
After hours: October 30 at 7:44:57 PM EDT
Trade ALLO on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreRecent transactions
Powered by Yahoo ScoutAllogene Therapeuticsreported 1 insider transaction: a salevalued at $62,957.64on 2026-08-21. Earl Martin Douglas(SVP, General Counsel) sold 29,697 sharesat $2.12per share; the filing shows 488,267 sharesremaining.
Major Holders
| Breakdown | |
|---|---|
| 11.02% | % of Shares Held by All Insider |
| 82.82% | % of Shares Held by Institutions |
| 93.08% | % of Float Held by Institutions |
| 279 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
|
Blackrock Inc.
|
30.15M | Jun 30, 2026 | 8.73% | 35,573,414 |
|
Frazier Life Sciences Management, L.P.
|
22.45M | Jun 30, 2026 | 6.50% | 26,487,067 |
|
Pfizer Inc
|
22.03M | Jun 30, 2026 | 6.38% | 25,997,806 |
|
State Street Corporation
|
19.03M | Jun 30, 2026 | 5.51% | 22,450,473 |
|
TPG GP A, LLC
|
18.72M | Jun 30, 2026 | 5.42% | 22,085,240 |
|
Sio Capital Management, LLC
|
13.32M | Jun 30, 2026 | 3.86% | 15,721,647 |
|
Primecap Management Company
|
13.12M | Jun 30, 2026 | 3.80% | 15,485,658 |
|
Vanguard Capital Management LLC
|
12.17M | Jun 30, 2026 | 3.52% | 14,356,629 |
|
FMR, LLC
|
12.01M | Jun 30, 2026 | 3.48% | 14,170,670 |
|
Citadel Advisors Llc
|
10.09M | Jun 30, 2026 | 2.92% | 11,903,568 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
|
Fidelity Select Portfolios-Select Biotechnology Portfolio
|
10.04M | Aug 31, 2026 | 2.91% | 11,852,973 |
|
VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund
|
9.39M | Jun 30, 2026 | 2.72% | 11,078,040 |
|
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF
|
9.26M | Sep 30, 2026 | 2.68% | 10,924,118 |
|
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund
|
8.67M | Jun 30, 2026 | 2.51% | 10,226,576 |
|
iShares Trust-iShares Russell 2000 ETF
|
6.95M | Sep 30, 2026 | 2.01% | 8,202,725 |
|
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund
|
3.48M | Jul 31, 2026 | 1.01% | 4,100,818 |
|
T. Rowe Price Health Sciences Fund, Inc.
|
3.44M | Jun 30, 2026 | 1.00% | 4,064,038 |
|
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund
|
3.22M | Jun 30, 2026 | 0.93% | 3,804,185 |
|
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund
|
2.91M | Jul 31, 2026 | 0.84% | 3,433,058 |
|
abrdn Life Sciences Investors
|
2.73M | Jun 30, 2026 | 0.79% | 3,223,467 |
